Scopolamine and Bumetanide drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 11 people who take Scopolamine and Bumetanide. Common interactions include anaemia among females, and bedridden among males.

The phase IV clinical study analyzes what interactions people who take Scopolamine and Bumetanide have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2023

11 people who take Scopolamine and Bumetanide together, and have interactions are studied.

What is Scopolamine?

Scopolamine has active ingredients of scopolamine. Currently, eHealthMe is studying from 4,455 Scopolamine users.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is used in fluid retention. Currently, eHealthMe is studying from 18,876 Bumetanide users.

Number of Scopolamine and Bumetanide reports submitted per year:

Scopolamine and Bumetanide drug interactions.

Common Scopolamine and Bumetanide drug interactions by gender *:


  1. Anaemia
  2. Chest pain
  3. Dehydration
  4. Hypotension
  5. Nausea
  6. Oedema
  7. Oedema peripheral
  8. Pleural effusion
  9. Pneumonia
  10. Pulmonary arterial hypertension


  1. Bedridden
  2. Blindness
  3. Chronic kidney disease
  4. Decubitus ulcer
  5. Hyperparathyroidism secondary
  6. Muscle contracture
  7. Nephrogenic anaemia
  8. Pneumonia
  9. Renal failure
  10. Wound infection

Common Scopolamine and Bumetanide drug interactions by age *:








  1. Atelectasis
  2. Blood bilirubin increased
  3. Pleural effusion
  4. Renal haemorrhage
  5. Renal impairment




  1. Acute respiratory failure
  2. Anaemia
  3. Arthralgia
  4. Asthenia
  5. Back pain
  6. Blood creatine increased
  7. Cancer pain
  8. Catheter site rash
  9. Chest pain
  10. Cor pulmonale


  1. Cardiogenic shock
  2. Chest pain
  3. Constipation
  4. Drug effect decreased
  5. Dry skin
  6. Dyspepsia
  7. Generalised oedema
  8. Hypoaesthesia oral
  9. Hypotension
  10. Nausea


  1. Anaemia
  2. Confusional state
  3. Dehydration
  4. Haemorrhage intracranial
  5. Metabolic encephalopathy
  6. Pneumonia
  7. Renal failure acute
  8. Urinary tract infection

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 54.55%
  2. Constipation: 5 people, 45.45%
  3. Muscle Spasms (muscle contraction): 5 people, 45.45%
  4. Nausea (feeling of having an urge to vomit): 5 people, 45.45%
  5. Pain: 4 people, 36.36%
  6. Stress And Anxiety: 4 people, 36.36%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 36.36%
  8. Cor Pulmonale Acute (rapid enlargement of the right ventricle of the heart): 3 people, 27.27%
  9. Hypotension (abnormally low blood pressure): 3 people, 27.27%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%

* Approximation only. Some reports may have incomplete information.

Do you take Scopolamine and Bumetanide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Scopolamine drug interactions:

Browse interactions between Scopolamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bumetanide drug interactions:

Browse interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on scopolamine and bumetanide (the active ingredients of Scopolamine and Bumetanide, respectively), and Scopolamine and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Scopolamine and Bumetanide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: